Skip to main content

UBS Group AG

Position in ENOV — Enovis CORP

CIK 1610520 ZURICH, V8

Position in ENOV

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$25,821,365
+$7,123,005 QoQ
Shares Held
1,247,409
+51.8% QoQ
Ownership
2.16%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#15
of 253 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 99% Shared 0% None 1%

Common Shares in ENOV Over Time

Shares Held

Position Value (USD)

Derivatives in ENOV

reported options exposure · as of Jun 30, 2026
CallValue
$32,655,906
CallShares
1,577,580
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Medical Devices

Healthcare · as of Jun 30, 2026

UBS Group AG holds $4,686,473,125 across 138 Medical Devices names. ENOV ranks #22 (0.6% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in ENOV

Export CSV
27 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $32,655,906 1,577,580
2026-06-30 $25,821,365 1,247,409
2026-03-31 $35,889,945 1,577,580
2026-03-31 $18,698,360 821,906
2025-12-31 $18,603,802 698,341
2025-12-31 $42,026,731 1,577,580
2025-09-30 $21,410,087 705,672
2025-09-30 $47,863,777 1,577,580
2025-06-30 $49,472,908 1,577,580
2025-06-30 $29,195,437 930,977
2025-03-31 $32,411,898 848,257
2025-03-31 $60,279,331 1,577,580
2024-12-31 $69,224,210 1,577,580
2024-12-31 $38,229,571 871,230
2024-09-30 $19,983,766 464,199
2024-09-30 $67,914,819 1,577,580
2024-06-30 $71,306,616 1,577,580
2024-06-30 $20,619,561 456,185
2024-03-31 $26,003,429 416,388
2024-03-31 $98,519,871 1,577,580
2023-12-31 $18,683,229 333,510
2023-09-30 $1,514,984 28,731
2023-06-30 $185,882 2,899
2023-03-31 $154,424 2,887
2022-12-31 $219,966 4,110
2022-09-30 $93,475 2,029
2022-06-30 $1,211,595 22,029